Varex Imaging Corp (VREX) company profile
Close on Nov 18, 2026Market cap $764.12MP/E 34.9Yield –
About Varex Imaging
Electronic Components, NEC, SIC 3679
Varex Imaging Corporation designs, manufactures, and services X-ray imaging components and specialized imaging systems. The company operates through two reportable segments: Medical and Industrial. Its Medical unit offers X-ray tubes, flat panel and photon counting detectors, connectors, and image-processing software for applications such as computed tomography and mammography. The Industrial unit supplies linear accelerators, scanners, and cargo inspection systems for security screening and non-destructive testing. Customers are primarily original equipment manufacturers, alongside independent service providers, distributors, and government agencies.
The enterprise employs around 2,400 full-time staff across engineering, manufacturing, and service facilities located in North America, Europe, and Asia. It conducts manufacturing in eight countries, including the United States, the United Kingdom, the Netherlands, Germany, Finland, the Philippines, China, and India, and maintains a regional service center in Germany. Commercial sales span three geographic regions: the Americas, EMEA, and APAC. Annually, the business produces over 27,000 X-ray tubes and 20,000 detectors. The excerpt does not state the location of its headquarters.
Summary of the business section of Varex Imaging's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Varex Imaging Corp
- Headquarters
- Salt Lake City, UT
- Address
- 1678 S. Pioneer Road 84104
- Phone
- (801) 972-5000
- Website
- vareximaging.com
- Employees
- 400, Oct 3, 2025
- Industry
- Electronic Components, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- October 2
- Auditor
- Deloitte & Touche LLP, Salt Lake City, Utah
Stock & identifiers
- Ticker
- VREX
- Exchange
- Nasdaq
- IPO date
- Jan 23, 2017
- Shares outstanding
- 42M, Aug 3, 2026
- Public float
- $339.30M, Apr 4, 2025
- Filer category
- Accelerated filer
- SEC CIK
- 1681622
- CUSIP
- 92214X106
- ISIN
- US92214X1063
- FIGI
- BBG00CZNLR47
- Share class FIGI
- BBG00CZNLR38
- LEI
- 549300CWYWPVCT8E9W67
- EIN
- 81-3434516
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Sunny Sanyal | President and CEO, Director | 231,892 |
| Matthew Aaron Martinez | Chief Legal Officer | 0 |
| Shubham Maheshwari | Chief Financial Officer | 269,972 |
| Karen L. Aranki | Chief Human Resources Officer | 8,893 |
| Jesse Don Merkley | SVP and GM, Industrial | 15,334 |
| Victor Hugo Garcia | SVP, Regulatory and QA | 23,360 |
| Mark S. Jonaitis | SVP and GM, X-Ray Sources | 77,341 |
| Andrew Hartmann | SVP and GM, Detectors | 36,182 |
| Kimberley E. Honeysett | SVP and CLO | 4,197 |
| Jay K. Kunkel | Director | 15,329 |
| Jocelyn D. Chertoff | Director | 42,194 |
| Timothy E. Guertin | Director | 26,777 |
| Walter M. Rosebrough Jr | Director | 52,654 |
| Christine A. Tsingos | Director | 42,655 |
| Kathleen Bardwell | Director | 12,102 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $4.63M | $4.14M | $1.39M | $97 | $135 |
| FY2024 | $4.75M | $1.12M | $1.29M | $96 | $128 |
| FY2023 | $4.52M | $3.66M | $1.19M | $152 | $104 |
| FY2022 | $4.47M | $1.17M | $1.29M | $171 | $96 |
| FY2021 | $4.69M | $10.13M | $1.22M | $231 | $128 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Sunny S. Sanyal President and Chief Executive Officer | $815.82K | $2.66M | $1.13M | $24.00K | $4.63M | -2% |
| Shubham Maheshwari Chief Financial Officer | $534.88K | $781.97K | $529.73K | $14.00K | $1.86M | +9% |
| Kimberley E. Honeysett Former SVP, CLO and Corporate Secretary | $420.91K | $479.96K | $343.15K | $22.30K | $1.27M | +8% |
| Andrew J. Hartmann SVP and General Manager, Detectors | $494.60K | $443.96K | $301.90K | $15.65K | $1.26M | +13% |
| Mark S. Jonaitis SVP and General Manager, X-Ray Sources | $405.91K | $443.96K | $312.79K | $21.53K | $1.18M | +1% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“We continually invest in research and development and employ approximately 400 individuals in product development related activities.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Sep 21, 2026 | Merger vote | Definitive merger proxy statement |
| Apr 1, 2021 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Aug 13, 2020 | Late filing | Notification of late filing |
| Feb 12, 2020 | Late filing | Notification of late filing |
| Dec 23, 2019 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Nov 27, 2019 | Late filing | Notification of late filing |
| Jul 7, 2017 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 1, 2017 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 11, 2016 | Spin-off | Registration as a new public company (Form 10), e.g. spin-off |
See a number that looks wrong?